Chronic Obstructive Pulmonary Disease
Conditions
Keywords
endothelial function, COPD, pulmonary function
Brief summary
The aim of the study is to assess the peripheral endothelial function in adult COPD (chronic obstructive pulmonary disease) patients and the relationship between the peripheral endothelial function and the pulmonary function.
Detailed description
The primary criteria is the peripheral endothelial function that will be assessed by the measure of flow-mediated dilation (reactive hyperemia-peripheral artery tone index). The pulmonary function will be assessed by the measures of the FEV1 (forced expiratory volume in one second), the forced vital capacity (FVC) and the expiratory flow between 25% and 75% (FEF25-75%). The relationship between these parameters of the pulmonary function and the peripheral endothelial function will be analyzed. In addition, a relationship between peripheral endothelial function and the severity of COPD (classification according to GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2010 and GOLD 2011 and the COPD assessment test, the cardiovascular risk factors (SCORE INdex) and the smoker status will be also assessed.
Interventions
DEVICECOPD patients
measure of peripheral endothelial function by the reactive hyperemia-peripheral artery tone index with a specific device (EndoPAT®)
Sponsors
Hopital Foch
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* COPD : FEV1/FVC \< 70% * Smokers or ex-smokers ( ≥ 10 pack-years) * No COPD exacerbation in the last three months * No history of asthma and no respiratory allergy
Exclusion criteria
* Pregnant or nursing women * Treatment with pulmonary vasodilators * Patients with a significant acute disease. A significant disease is defined as a disease which, in the opinion of the investigator, may influence the results of the trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| measure of reactive hyperemia-peripheral artery tone index | Day 1 | measure of reactive hyperemia-peripheral artery tone index |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| measure of Forced expiratory flow in one second | day 1 | measure of Forced expiratory flow in one second |
| measure of forced vital capacity | day 1 | measure of forced vital capacity |
| measure of expiratory flow between 25% and 75% (FEF25-75%). | day 1 | measure of expiratory flow between 25% and 75% (FEF25-75%). |
Countries
France
Outcome results
None listed